Cell-based therapy has been studied as an attractive strategy for therapeutic angiogenesis. However, obtaining a stable vascular structure remains a challenge due to the poor interaction of transplanted cells with native tissue and the difficulty in selecting the optimal cell source. In this study, we developed a cell patch of cocultured human umbilical vein endothelial cells (HUVECs) and smooth muscle cells (SMCs) using thermosensitive hydrogels for regeneration of mature vasculatures. In vitro characterization of HUVECs in the cocultured group revealed the formation of a mesh-like morphology over 5 days of culture. Vascular endothelial growth factor expression was also upregulated in the cocultured group compared with HUVECs only. The cell patch seeded with HUVECs, SMCs, or both cell type was prepared on the synthetic thermosensitive and cell interactive hydrogels, and readily detached from the hydrogel within 10 min by expansion of the hydrogel when the temperature was decreased to 4°C. We then investigated the therapeutic effect of the cell patch using a hind limb ischemic model of an athymic mouse. Overall, the group that received a cell patch of cocultured HUVECs and SMCs had a significantly retarded rate of necrosis with a significant increase in the number of arterioles and capillaries for 4 weeks compared with the groups transplanted with only HUVECs or SMCs. Dual staining of smooth muscle alpha actin and human nuclear antigen showed that the implanted cell patch was partially involved in vessel formation. In summary, the simple transplantation of a cocultured cell patch using a hydrogel system could enhance therapeutic angiogenesis through the regeneration of matured vascular structures.
Get full access to this article
View all access options for this article.
References
1.
LawallH., BramlageP., and AmannB.Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Thromb Haemost, 103, 696, 2010.
2.
HuangC.-C., ChenD.-Y., WeiH.-J., LinK.-J., WuC.-T., LeeT.-Y., HuH.-Y., HwangS.-M., ChangY., and SungH.-W.Hypoxia-induced therapeutic neovascularization in a mouse model of an ischemic limb using cell aggregates composed of HUVECs and cbMSCs. Biomaterials, 34, 9441, 2013.
GornikH.L., and BeckmanJ.A.Peripheral arterial disease. Circulation, 111, E169, 2005.
5.
TongersJ., RoncalliJ.G., and LosordoD.W.Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation. Microvasc Res, 79, 200, 2010.
6.
TongersJ., RoncalliJ.G., and LosordoD.W.Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age. Circulation, 118, 9, 2008.
7.
SievekingD.P., and NgM.K.Cell therapies for therapeutic angiogenesis: back to the bench. Vasc Med, 14, 153, 2009.
8.
LosordoD.W., and DimmelerS.Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation, 109, 2692, 2004.
9.
YangJ., YamatoM., KohnoC., NishimotoA., SekineH., FukaiF., and OkanoT.Cell sheet engineering: recreating tissues without biodegradable scaffolds. Biomaterials, 26, 6415, 2005.
10.
ParkK.M., ShinY.M., JoungY.K., ShinH., and ParkK.D.In situ forming hydrogels based on tyramine conjugated 4-Arm-PPO-PEO via enzymatic oxidative reaction. Biomacromolecules, 11, 706, 2010.
11.
ParkK.M., JunI., JoungY.K., ShinH., and ParkK.D.In situ hydrogelation and RGD conjugation of tyramine-conjugated 4-arm PPO-PEO block copolymer for injectable bio-mimetic scaffolds. Soft Matter, 7, 986, 2011.
12.
LeeJ., JunI., ParkH.J., KangT.J., ShinH., and ChoS.W.Genetically engineered myoblast sheet for therapeutic angiogenesis. Biomacromolecules, 15, 361, 2014.
13.
KimS.J., JunI., KimD.W., LeeY.B., LeeY.J., LeeJ.H., ParkK.D., ParkH., and ShinH.Rapid transfer of endothelial cell sheet using a thermosensitive hydrogel and its effect on therapeutic angiogenesis. Biomacromolecules, 14, 4309, 2013.
14.
RehmanJ., LiJ.L., OrschellC.M., and MarchK.L.Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation, 107, 1164, 2003.
15.
CarmelietP.Mechanisms of angiogenesis and arteriogenesis. Nat Med, 6, 389, 2000.
16.
KawamotoA., TkebuchavaT., YamaguchiJ.I., NishimuraH., YoonY.S., MillikenC., UchidaS., MasuoO., IwaguroH., MaH., HanleyA., SilverM., KearneyM., LosordoD.W., IsnerJ.M., and AsaharaT.Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation, 107, 461, 2003.
17.
Heydarkhan-HagvallS., HeleniusG., JohanssonB.R., LiJ.Y., MattssonE., and RisbergB.Co-culture of endothelial cells and smooth muscle cells affects gene expression of angiogenic factors. J Cell Biochem, 89, 1250, 2003.
18.
OwensG.K., KumarM.S., and WamhoffB.R.Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev, 84, 767, 2004.
19.
EvensenL., MicklemD.R., BloisA., BergeS.V., AarsaetherN., Littlewood-EvansA., WoodJ., and LorensJ.B.Mural cell associated VEGF is required for organotypic vessel formation. PLoS One, 4, e5798, 2009.
20.
SatoY., TsuboiR., LyonsR., MosesH., and RifkinD.B.Characterization of the activation of latent Tgf-beta by cocultures of endothelial-cells and pericytes or smooth-muscle cells—a self-regulating system. J Cell Biol, 111, 757, 1990.
21.
FillingerM.F., SampsonL.N., CronenwettJ.L., PowellR.J., and WagnerR.J.Coculture of endothelial cells and smooth muscle cells in bilayer and conditioned media models. J Surg Res, 67, 169, 1997.
22.
GrosskreutzC.L., Anand-ApteB., DuplaaC., QuinnT.P., TermanB.I., ZetterB., and D'AmoreP.A.Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc Res, 58, 128, 1999.
23.
LimbourgA., KorffT., NappL.C., SchaperW., DrexlerH., and LimbourgF.P.Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia. Nat Protoc, 4, 1737, 2009.
24.
HiattW.R.Medical treatment of peripheral arterial disease and claudication. N Engl J Med, 344, 1608, 2001.
25.
JudeE.B., EleftheriadouI., and TentolourisN.Peripheral arterial disease in diabetes—a review. Diabet Med, 27, 4, 2010.
26.
RufaihahA.J., HuangN.F., JameS., LeeJ.C., NguyenH.N., ByersB., DeA., OkogbaaJ., RollinsM., Reijo-PeraR., GambhirS.S., and CookeJ.P.Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler Throm Vas Biol, 31, E72, 2011.
27.
ChenD.Y., WeiH.J., LinK.J., HuangC.C., WangC.C., WuC.T., ChaoK.T., ChenK.J., ChangY., and SungH.W.Three-dimensional cell aggregates composed of HUVECs and cbMSCs for therapeutic neovascularization in a mouse model of hindlimb ischemia. Biomaterials, 34, 1995, 2013.
28.
ShepherdB.R., JayS.M., SaltzmanW.M., TellidesG., and PoberJ.S.Human aortic smooth muscle cells promote arteriole formation by coengrafted endothelial cells. Tissue Eng Part A, 15, 165, 2009.
29.
DarlandD.C., MassinghamL.J., SmithS.R., PiekE., St-GeniezM., and D'AmoreP.A.Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev Biol, 264, 275, 2003.
30.
PetersE.B., ChristoforouN., LeongK.W., and TruskeyG.A.Comparison of mixed and lamellar coculture spatial arrangements for tissue engineering capillary networks in vitro. Tissue Eng Part A, 19, 697, 2013.
31.
YamaharaK., SoneM., ItohH., YamashitaJ.K., Yurugi-KobayashiT., HommaK., ChaoT.H., MiyashitaK., ParkK., OyamadaN., SawadaN., TauraD., FukunagaY., TamuraN., and NakaoK.Augmentation of neovascularizaiton in hindlimb ischemia by combined transplantation of human embryonic stem cells-derived endothelial and mural cells. PLoS One, 3, e1666, 2008.
32.
YoonC.-H., HurJ., ParkK.-W., KimJ.-H., LeeC.-S., OhI.-Y., KimT.-Y., ChoH.-J., KangH.-J., and ChaeI.-H.Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells the role of angiogenic cytokines and matrix metalloproteinases. Circulation, 112, 1618, 2005.
33.
LeeW.Y., ChangY.H., YehY.C., ChenC.H., LinK.M., HuangC.C., ChangY., and SungH.W.The use of injectable spherically symmetric cell aggregates self-assembled in a thermo-responsive hydrogel for enhanced cell transplantation. Biomaterials, 30, 5505, 2009.
34.
HuangC.C., ChenD.Y., WeiH.J., LinK.J., WuC.T., LeeT.Y., HuH.Y., HwangS.M., ChangY., and SungH.W.Hypoxia-induced therapeutic neovascularization in a mouse model of an ischemic limb using cell aggregates composed of HUVECs and cbMSCs. Biomaterials, 34, 9441, 2013.
35.
MehtaG., HsiaoA.Y., IngramM., LukerG.D., and TakayamaS.Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J Control Release, 164, 192, 2012.
36.
SekineH., ShimizuT., HoboK., SekiyaS., YangJ., YamatoM., KurosawaH., KobayashiE., and OkanoT.Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation, 118, S145, 2008.
37.
SeidlitsS.K., DrinnanC.T., PetersenR.R., ShearJ.B., SuggsL.J., and SchmidtC.E.Fibronectin-hyaluronic acid composite hydrogels for three-dimensional endothelial cell culture. Acta Biomater, 7, 2401, 2011.
38.
LeeY.B., JunI., BakS., ShinY.M., LimY.M., ParkH., and ShinH.Reconstruction of vascular structure with multicellular components using cell transfer printing methods. Adv Healthc Mater, 3, 1465, 2014.
39.
KimD.W., JunI., LeeT.J., LeeJ.H., LeeY.J., JangH.K., KangS., ParkK.D., ChoS.W., KimB.S., and ShinH.Therapeutic angiogenesis by a myoblast layer harvested by tissue transfer printing from cell-adhesive, thermosensitive hydrogels. Biomaterials, 34, 8258, 2013.
40.
YuJ., GuY., DuK.T., MihardjaS., SieversR.E., and LeeR.J.The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. Biomaterials, 30, 751, 2009.
41.
ZhuJ.Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering. Biomaterials, 31, 4639, 2010.
TrkovS., EngG., Di LiddoR., ParnigottoP.P., and Vunjak-NovakovicG.Micropatterned three-dimensional hydrogel system to study human endothelial—mesenchymal stem cell interactions. J Tissue Eng Regen Med, 4, 205, 2010.
50.
AuP., TamJ., DudaD.G., LinP.C., MunnL.L., FukumuraD., and JainR.K.Paradoxical effects of PDGF-BB overexpression in endothelial cells on engineered blood vessels in vivo. Am J Pathol, 175, 294, 2009.
51.
ChoS.W., YangF., SonS.M., ParkH.J., GreenJ.J., BogatyrevS., MeiY., ParkS., LangerR., and AndersonD.G.Therapeutic angiogenesis using genetically engineered human endothelial cells. J Control Release, 160, 515, 2012.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
